Anti-Androgens in Hirsutism

The document discussed the use of anti-androgens, specifically cyproterone acetate (CPA), in the treatment of hirsutism. It reviewed various studies and clinical trials that demonstrated CPA's effectiveness in reducing hair growth, sebaceous secretion, and other endocrine parameters in hirsute subjects. The studies cited included both individual case studies and larger clinical trials, highlighting CPA's potential as a therapeutic agent for managing hirsutism and related conditions such as acne and virilism. The findings supported the use of CPA as a viable treatment option for patients with these conditions.